Vagal Nerve Stimulation for the Treatment of Persistent AF

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05833373

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05833373
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05833373. Randomized; triple masking; primary purpose treatment. Start 2023-11-06 (actual); primary completion 2025-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vagal Nerve Stimulation for the Treatment of Persistent AF
Acronym
VAST-AF
Intervention (Device)
Vagal stimulation with the device tVNS from tVNS Technologies GmbH
Intervention (Device)
Sham stimulation with the device tVNS from tVNS Technologies GmbH
Lead sponsor
Krankenhaus Hetzelstift (class: other)
Collaborator
Deutsche Stiftung für Herzforschung (class: other)
Collaborator
Johannes Gutenberg University Mainz (class: other)

Record details

Record id
cardio:ct-nct05833373
Content hash
2339125968b4f6dc97e4d86d6dce3e0305b218ce757e12e75ba2e82305463901